The Double-edged Sword Role of Fibroblasts in the Interaction with Cancer Cells; an Agent-based Modeling Approach
Overview
Affiliations
Fibroblasts as key components of tumor microenvironment show different features in the interaction with cancer cells. Although, Normal fibroblasts demonstrate anti-tumor effects, cancer associated fibroblasts are principal participant in tumor growth and invasion. The ambiguity of fibroblasts function can be regarded as two heads of its behavioral spectrum and can be subjected for mathematical modeling to identify their switching behavior. In this research, an agent-based model of mutual interactions between fibroblast and cancer cell was created. The proposed model is based on nonlinear differential equations which describes biochemical reactions of the main factors involved in fibroblasts and cancer cells communication. Also, most of the model parameters are estimated using hybrid unscented Kalman filter. The interactions between two cell types are illustrated by the dynamic modeling of TGFβ and LIF pathways as well as their crosstalk. Using analytical and computational approaches, reciprocal effects of cancer cells and fibroblasts are constructed and the role of signaling molecules in tumor progression or prevention are determined. Finally, the model is validated using a set of experimental data. The proposed dynamic modeling might be useful for designing more efficient therapies in cancer metastasis treatment and prevention.
Modeling critical dosing strategies for stromal-induced resistance to cancer therapy.
Kraut A, Garvey C, Strelez C, Mumenthaler S, Foo J NPJ Syst Biol Appl. 2025; 11(1):16.
PMID: 39915486 PMC: 11802896. DOI: 10.1038/s41540-025-00495-0.
Towards verifiable cancer digital twins: tissue level modeling protocol for precision medicine.
Kemkar S, Tao M, Ghosh A, Stamatakos G, Graf N, Poorey K Front Physiol. 2024; 15:1473125.
PMID: 39507514 PMC: 11537925. DOI: 10.3389/fphys.2024.1473125.
Agent-based modeling in cancer biomedicine: applications and tools for calibration and validation.
Cogno N, Axenie C, Bauer R, Vavourakis V Cancer Biol Ther. 2024; 25(1):2344600.
PMID: 38678381 PMC: 11057625. DOI: 10.1080/15384047.2024.2344600.
Heidary Z, Javanmard S, Izadi I, Zare N, Ghaisari J Sci Rep. 2022; 12(1):16242.
PMID: 36171274 PMC: 9519582. DOI: 10.1038/s41598-022-20634-5.
Fotsitzoudis C, Koulouridi A, Messaritakis I, Konstantinidis T, Gouvas N, Tsiaoussis J Cancers (Basel). 2022; 14(18).
PMID: 36139552 PMC: 9497276. DOI: 10.3390/cancers14184394.